To,

The Members, 

Shivam Chemicals Limited


The Board of Directors of the Company have great pleasure in presenting the 15th
Annual Report of the Company together with Audited Standalone and Consolidated Financial
Statement for the Financial year ended 31st March, 2025. This report states
compliances as per the requirements of the Companies Act, 2013 ("the Act"), the
Secretarial Standards, the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("Listing Regulations") and other
rules and regulations as applicable to the Company.


1. Financial Results:



Our Company was incorporated with the Registrar of Companies, Mumbai, Maharashtra,
India, on 12th October, 

2010 with the Corporate Identity No. U24100MH2010PLC208870. 

The Company was listed on the SME platform of Bombay Stock Exchange on 30th
April, 2024 and the revised 

Corporate Identity No. is L24100MH2010PLC208870


• Standalone Financial Performance:



The highlight of the Standalone financial performance of the Company for the year ended
31st March, 2025 is summarized follows: 


  

    
Particulars
    
FY 2024-25
    
FY 2023-24
  
  

    
Net Revenue From Operations
    
Rs.20,736.05/-
    
Rs.13,633.82/-
  
  

    
Other Income
    
Rs.74.36/-
    
Rs.5.75/-
  
  

    
Total Income
    
Rs.20,810.40/-
    
Rs.13,639.57/-
  
  

    
Total Expenses Excluding Depreciation, Interest, Tax & Amortization
    
Rs.20,336.91/-
    
Rs.13,324.90/-
  
  

    
Profit/(Loss) Before Depreciation, Interest,Tax & Amortization
    
Rs.473.49/-
    
Rs.314.67/-
  
  

    
Less: Interest & Financial Charges
    
Rs.118.54/-
    
Rs.28.97/-
  
  

    
Depreciation & Amortization
    
Rs.8.93/-
    
Rs.7.09/-
  
  

    
Profit /(Loss) Before Tax and Exceptional Items
    
Rs.346.03/-
    
Rs.278.61/-
  
  

    
Exceptional Item
    
--
    
Rs.5.32/-
  
  

    
Profit/(Loss) Before Tax
    
Rs.346.03/-
    
Rs.283.93/-
  
  

    
Less: Provision For Tax
    

    

  
  

    
- Current Tax
    
Rs.89.44/-
    
Rs.82.38/-
  
  

    
- Short Provision of Tax
    
--
    
--
  
  

    
- Deferred Tax Assets/ (Liabilities)
    
(Rs.0.54/-)
    
Rs.0.91/-
  
  

    
Net Profit/(Loss) After Tax
    
Rs.257.14/-
    
Rs.200.64/-
  



• Consolidated Financial Performance:



The highlight of the Consolidated financial performance of the Company for the year
ended 31st March, 2025 is summarized as follows: 


  

    
Particulars
    
FY 2024-25
    
FY 2023-24
  
  

    
Net Revenue From Operations
    
Rs.22,413.34/-
    
Rs.14,654.11/-
  
  

    
Other Income
    
Rs.142.61/-
    
Rs.31.83/-
  
  

    
Total Income
    
Rs.22,555.95/-
    
Rs.14,685.94/-
  
  

    
Total Expenses Excluding Depreciation, Interest, Tax &
    
Rs.21,955.26/-
    
Rs.14,296.15/-
  
  

    
Amortization
    

    

  
  

    
Profit/(Loss) Before Depreciation, Interest, Tax &
    
Rs.600.69/-
    
Rs.389.79/-
  
  

    
Amortization
    

    

  
  

    
Less: Interest & Financial Charges
    
Rs.169.24/-
    
Rs.76.44/-
  


 


  

    
Depreciation & Amortization
    
Rs.128.10/-
    
Rs.114.50/-
  
  

    
Profit /(Loss) Before Tax and Exceptional Items
    
Rs.303.34/-
    
Rs.198.84/-
  
  

    
Exceptional Item
    
--
    
Rs.5.32/-
  
  

    
Profit/(Loss) Before Tax
    
Rs.303.34/-
    
Rs.204.16/-
  
  

    
Less: Provision For Tax
    

    

  
  

    
- Current Tax
    
Rs.89.44/-
    
Rs.82.60/-
  
  

    
- Short Provision of Tax
    
--
    
--
  
  

    
- Deferred Tax (Assets)/ Liabilities
    
Rs.4.61/-
    
Rs.0.91/-
  
  

    
Net Profit/(Loss) After Tax
    
Rs.209.30/-
    
Rs.120.65/-
  



2. Business Performance Overview:



Our company is a manufacturer of Hydrated Lime (Calcium Hydroxide) & a distributor
of various products such as Poultry feed supplement, Feed Phosphates, Limestone Powder,
etc. with rich experience and knowledge we have built a well-established marketing network
across India and we distribute animal feed products for various well renowned manufacture
over the years, we have successfully supplied an impressive quantity of over 

2.50 Lakh metric tons of various products, reflecting our commitment to meeting the
demands of the market. The cumulative value of these supplied products has exceeded INR
7,500 million, underscoring our financial significance in the sector. With an average
monthly sales volume of 2,650 metric tons, we maintain a consistent presence and
contribute to the steady flow of products in the market. Our journey began with a primary
focus on animal feed supplement trading till FY 2022-23 and our evolution into
manufacturing is happened through the establishment of a 100% owned subsidiary.

Our wholly owned subsidiary company Shivam Chemicals and Minerals Private Limited is
located at Dahej Gujarat with a manufacturing capacity of 60,000 MT. They are engaged in
manufacturing of Hydrated lime (Calcium hydroxide) product.


Standalone Financial Performance Overview:


During the year under review, the Company has earned a total revenue of Rs.20,810.40/-
Lakhs for the year ended 31st March, 2025 as against Rs.13,639.57/- Lakhs in
the previous financial year.

The Company has recorded a profit (PBT) of Rs.346.03/- Lakhs for the year ended 31st
March, 2025 as compared to Rs.283.93/- Lakhs in the previous financial year.

The Profit/ (Loss) after Tax (PAT) for the year ended 31st March, 2025 stood
at Rs.257.14/- Lakhs as compared to Rs.200.64/- Lakhs in the previous financial year.


Consolidated Financial Performance Overview:


During the year under review, the Company has earned a total revenue of Rs.22,555.95/-
Lakhs for the year ended 31st March, 2025 as against Rs.14,685.94/- Lakhs in
the previous financial year.

The Company has recorded a profit (PBT) of Rs.303.34/- Lakhs for the year ended 31 st
March, 2025 as compared to Rs.204.16/- Lakhs in thepreviousfinancialyear.

(Loss) TheProfit/ after Tax (PAT) for the year ended 31 st March, 2025 stood
at Rs.209.30/- Lakhs as compared to Rs.120.65/- Lakhs in the previous financial year.


Summarised Overview:


? Significant increase in volumes and turnover across all business activities.

? Diversification into new product assortments and entry into export markets supported
overall growth.

? Operational scaling and improved capacity utilization enhanced efficiencies.


3. Significant Events during the Financial Year:


Initial Public Offer of the Shares of the Company & Listing on SME Platform of BSE:


During the previous financial year, the Company had successfully come out with its
maiden SME IPO (Initial Public Offering). The Public issue consisted of 45,87,000 Equity
Shares at price of Rs.44/- (including a premium of Rs.34/- Equity Shares) aggregating to
Rs.2,018.28 Lakhs which was opened for subscription on 23rd April, 2024 and
closed on 25th April, 2024 for all the applicants. The Company received the
overwhelming response for the said IPO issue and said shares got listed on the BSE –
SME platform on 30th April, 2024. Subsequent to 


completion of IPO, the paid-up share capital of the Company increased to
Rs.16,98,70,000/- 


4. Material changes and commitment between the end of the Financial year to
which this Financial statements relate and the date of the report of the Board:



There have been no material changes and commitments affecting the financial position of
the Company which have occurred between the end of the financial year to which these
financial statements relate and the date of this report. 

There are following eventswhichoccurredbetweentheendoffinancialyear to which this
report relate and the date of the report of the Board:

Resignation of Mr. Manish Tarachand Pande, Independent Director of the Company:



Mr. Manish Tarachand Pande has resigned from the post of, Independent Director of the
Company with effect from 9th April, 2025. 


Resignation of Ms. Rishita Taparia, Company Secretary and Compliance Officer of the
Company:


Ms. Rishita Taparia has resigned from the post of Company Secretary and Compliance
Officer of the Company with effect from 20th August, 2025.


5. Change in the nature of business:



The Company continues to be engaged in manufacturing of Hydrated Lime (Calcium
Hydroxide) & a distributor of various products such as Poultry feed supplement, Feed
Phosphates, Limestone Powder, etc. and there is no change in the nature of the business of
the Company during the Financial year under review. 


6. Dividend:



In view of strengthening its financial position, the Board of Directors of the Company
is of the view to plough back the profits of the Company in to the business.


7. Share Capital:


Authorised Share Capital:


The Authorised Share Capital of the is Rs.18,00,00,000/- (Rupees Eighteen Crore Only)
divided into 1,80,00,000

(One Crore Eighty Lacs) equity shares of Rs. 10/- (Rupees Ten) each. There has been no
change in the 

Authorized Share Capital of the Company in the financial year.


Issued and Paid Up Share Capital:


The Company has paid up share capital of Rs.16,98,70,000/- (Rupees Sixteen Crore
Ninety-Eight Lacs Seventy Thousand Only) divided into 1,69,87,000 (One Crore Sixty-Nine
Lacs Eighty-Seven Thousand equity shares of

Rs. 10/- (Rupees Ten Only) each, as on 31st March, 2025. 


8. Utilization of IPO Fund:



The Initial Public Offer fund has been utilized for the purpose for which it is raised
and the Company has no outstanding amount as on date.


9. Transfer to reserves:



Your Directors do not propose to carry any amount to any reserves, during the Financial
year.


10. Deposits:


The Company has neither accepted nor renewed any deposits falling within the purview of
Section 73 of the Companies Act, 2013 read with Companies (Acceptance of Deposits) Rules
2014 as amended from time to time, during the year under review.

There were no unclaimed or unpaid deposits as on 31st March, 2025.


11. Annual Return:


Pursuant to the amendments to Section 134(3)(a) and Section 92(3) of the Act read with
Rule 12 of the Companies (Management and Administration) Rules, 2014, the Annual Return in
Form MGT-7 for the Financial Year ended 31st March, 2025 is available on the
Company's website and can be accessed at https://www. shivamchem.com. 


12. Transfer of Unclaimed Dividend to Investor Education and Protection Fund:


There was no amount outstanding to be an Unclaimed Dividend to Investor Education and
Protection Fund during the FY 2024-2025.


13. Corporate Governance:


As per regulation 15(2) of the SEBI(LODR) Regulations, 2015, the Compliance with
respect to the Corporate Governance provisions shall not apply in respect of the following
class of the Companies: a) Listed entity having paid up equity share capital not exceeding
Rs.10 Crore and Net Worth not exceeding Rs.25 Crore, as on the last day of the previous
Financial year; b) Listed entity which has listed its specified securities on the SME
Exchange.

Since, our Company falls within the ambit of aforesaid exemption (b); hence compliance
with the provision of Corporate Governance shall not apply to the Company and it does not
form the part of the Annual Report for the Financial Year 2024-2025.


14. Non-Applicability of the Indian Accounting Standards:


As per Provision to regulation Rule 4(1) of the Companies (Indian Accounting Standards)
Rules, 2015 notified vide Notification No. G.S.R 111 (E) on 16th February,
2015, Companies whose shares are listed on SME exchange as referred to in Chapter XB of
SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009, are exempted from
the compulsory requirements of adoption of IND-AS w.e.f. 1st April, 2017. As
your Company is also listed on SME Platform of BSE Limited, is covered under the exempted
category and is not required to comply with IND-AS for preparation of Financial statements
beginning with period on or after 1st April, 2017.


15. Directors and Key Managerial Personnel:


The Board received declarations from all the Directors under Section 164 and other
applicable provisions, if any, of the Companies Act, 2013 that none of the Directors of
the Company are disqualified under the provisions of the

Companies Act, 2013 ("Act") or under the SEBI (Listing Obligation and
Disclosure Requirements) Regulations 2015.

The Board of Directors of the Company, at present, comprises of 6 Directors, who have
wide and varied experience in different disciplines of corporate functioning. The present
composition of the Board consists of one Managing Director, two Executive Directors and
Two Non-Executive Independent Directors.

The details are as follows:


  

    
SR. NO.
    
NAME
    
DIN NO.
    
DESIGNATION
  
  

    
1.
    
Mr. Sanjiv Girdharlal Vasant
    
DIN.03036854
    
Managing Director
  
  

    
2.
    
Mr. Soham Sanjiv Vasant
    
DIN.03036861
    
CFO& Whole-time director
  
  

    
3.
    
Mr. Shivam Sanjiv Vasant
    
DIN.08512942
    
Whole-time director
  
  

    
4.
    
Ms. Himani Bhootra
    
DIN.09811030
    
Independent Director
  
  

    
5.
    
Mr. Kunal Bharat Shingala
    
DIN.09838502
    
Independent Director
  
  

    
6.
    
Mr. Manish Tarachand Pande
    
DIN.08712019
    
Independent Director
  
  

    

    
(Up to 9th April 2025)
    

    

  



16. Directors' Responsibility Statement:


Pursuant to the requirement under section 134(5) of the Companies Act, 2013 with
respect to Directors' 

Responsibility Statement, it is hereby confirmed that:

(i) In the preparation of the Financial Statements for the Financial year ended 31st
March, 2025, the applicable accounting standards had been followed along with proper
explanation relating to material departures; (ii) The Directors had selected such
accounting policies and applied them consistently and made judgments and estimates that
are reasonable and prudent so as to give a true and fair view of the state of affairs of
the Company as at 31st March, 2025 and of the Profit and Loss of the Company
for that period; (iii) The Directors had taken proper and sufficientcare for the
maintenance of adequate accounting records in accordance with the provisions of the
Companies Act, 2013 for safeguarding the assets of the Company and for preventing and
detecting fraud and other irregularities; (iv) The Directors had prepared the Financial
Statements on a going concern basis; (v) The Directors had laid down Internal Financial
Controls to be followed by the Company and that such Internal Financial Controls are
adequate and were operating effectively; (vi) The Directors had devised proper systems to
ensure compliance with the provisions of all applicable laws and that such systems were
adequate and operating effectively.


17. Disclosures By Directors:


The Board of Directors have submitted notice of interest in Form MBP 1 under Section
184(1) as well as information by Directors in Form DIR 8 under Section 164(2) and
declarations as to compliance with the

Companies Act, 2013.


18. Disqualifications Of Directors:


During the Financial Year 2024-2025 under review the Company has received Form DIR-8
from all Directors as required under the provisions of Section 164(2) of the Companies
Act, 2013 read with Companies (Appointment and Qualification of Directors) Rules, 2014
that none of the Directors of your Company is disqualified.


19. SEBI Complaints Redress System (SCORES):


The investor complaints are processed in a centralized web based complaints redress
system. The salient features of this system are centralized database of all complaints,
online upload of Action Taken Reports\(ATRs) by the concerned companies and online viewing
by investors of actions taken on the complaint and its current status. Your Company has
been registered on SCORES and makes every effort to resolve all investor complaints
received through SCORES or otherwise within the statutory time limit from the receipt of
the complaint. The Company has not received any complaint on the SCORES during Financial
year 2024-25.


20. Details of the Complaint Received/Solved/Pending during the year:



  

    
Sr. No.
    
Nature of Complaint
    
Nature of Complaint
    
Complaints solved
    
Complaints pending
  
  

    
1.
    
Non-receipt of shares certificate after transfer etc.
    
Nil
    
Nil
    
Nil
  
  

    
2.
    
Non-receipt of dividend warrants
    
Nil
    
Nil
    
Nil
  
  

    
3.
    
Query regarding demat credit
    
Nil
    
Nil
    
Nil
  
  

    
4.
    
Others
    
Nil
    
Nil
    
Nil
  
  

    

    
Total
    
Nil
    
Nil
    
Nil
  



21. Statutory Auditors and Audit Report:


As members must be aware that pursuant to provisions of section 139 of the Companies
Act, 2013, M/s PSRD and Co., Chartered Accountants, were appointed as Statutory Auditors
of the Company for period of five years commencing from the conclusion of 14th
Annual General Meeting till the conclusion of 19th Annual General Meeting.

Statutory Auditor's comments on the Annual Financial Statements of the Company for the
year ended 31st March, 2025, are self-explanatory and do not require any
explanation as per provisions of Section 134(3)(f) of the Companies Act, 2013.

There were no qualifications, reservations or adverse remarks or disclaimer made by the
Statutory Auditor in their reports on the Annual Financial Statement of the Company for
the year under review. 


22. Details of Fraud reported by the Auditor:


As per Auditor's report, no fraud u/s 143(12) has been reported by the Auditor.


23. Board's Comment on Auditor's Report:


The observations of the Statutory Auditors, when read together with the relevant notes
to accounts and other accounting policies are self-explanatory and do not call for any
further comment.


24. Secretarial Audit:


The Board had appointed M/s. DSM & Associates, Company Secretaries, to carry out
Secretarial Audit of the Company under the provisions of Section 204 of the Companies Act,
2013 and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014,
for the Financial Year 2024-25. The Report of the Secretarial Auditor for Financial Year
2024-25 is annexed to this report.

The Company has complied with Secretarial Standards issued by the Institute of Company
Secretaries of India on Meetings of the Board of Directors and General Meetings.

There are no adverse observations in the Secretarial Audit Report which call for
explanation.


25. Appointment of Internal Auditor:


Pursuant to per Section 138 of the Companies Act, 2013 of the Companies Act, 2013, M/s.
Bharat Kanakia &

Associates, Chartered Accountants, was appointed as the Internal Auditor of the
Company.


26. Disclosure relating to subsidiaries, joint ventures and associate companies:


As on 31st March, 2025 the Company has Shivam Chemicals and Minerals Private
Limited as 100% subsidiary company, details of which are provided in form AOC-1 attached
as annexure - 1.


27. Compliance of Applicable Secretarial Standards:


The Company has ensured compliance with the mandated Secretarial Standard I & II
issued by the Institute of Company Secretaries of India with respect to Board meetings and
general meetings respectively and approved by the Central Government under section 118(10)
of the Companies Act, 2013.


28. Management Discussion and Analysis Report:


In terms of Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements)
Regulation, 2015 read with Schedule V of SEBI (Listing Obligation and Disclosure
Requirements) Regulations 2015, Management Disclosure and Analysis Report (MDA) is
attached Annexure - 2.


29. Maternity Benefit: Rule 8(5)(xiii) of Companies (Accounts), Rules, 2014:


The Company affirm that it has duly complied with all the provision of Maternity
Benefits to eligible woman employees during the year.


30. Declaration By Independent Directors:


The Company had received a declaration from all the Independent Director of the Company
confirmingthat they meet the criteria of independence as prescribed under Section 149(6)
of the Companies Act, 2013 and that they are not aware of any circumstance or situation,
which exist or may be reasonably anticipated, that could impair or impact their ability to
discharge their duties with an objective independent judgment and without any external
influence. In the opinion of the Board,theyfulfilthe conditions of independence as
specified in the Act and the

Listing regulations and are independent of the management.


31. Independent Directors' Meeting:


With reference to Clause VII of Schedule IV to the Companies Act, 2013 it is provided
that a separate meeting of Independent Directors should be held at least once in a year.
Accordingly, there was a separate meeting of the Independent Directors held on 29th
May, 2024. The meeting was chaired by Ms. Himani Bhootra.

The valuable inputs, as provided by the Independent Directors were noted and
implemented in the forthcoming meetings.


32. Evaluation of Board, Its Committee, and Individual Directors:


Pursuant to the provisions of the Companies Act and the SEBI Listing Regulations, a
structured questionnaire was prepared for evaluating the performance of Board, its
Committees and Individual Director including Independent Directors. The questionnaires
were prepared after taking into consideration the various facets related to working of
Board, its Committee and roles and responsibilities of Director. The Board and the
Nomination and Remuneration Committee reviewed the performance of the Individual Directors
including Independent Directors on the basis of the criteria and framework adopted by the
Board. Further, the performance of Board as a whole and committees were evaluated by the
Board after seeking inputs from all the Directors on the basis of various criteria. The
Board of Directors expressed their satisfaction with the evaluation process. In a separate
meeting of Independent Directors, the performance of Non-Independent Directors,
performance of Board as a whole and performance of the Chairman was evaluated, taking into
account the views of the Executive Directors and Non-Executive Directors.


33. Meeting of Directors:


Board Meeting & Shareholders Meeting:



The Board meets at regular intervals to discuss and decide on Company's business policy
and strategy apart from other Board business. The notice of Board Meeting is given well in
advance to all the Directors. The Agenda of the Board/ Committee meetings was circulated
to all the Directors as per the Provisions of Companies Act, 2013 and rules made
thereunder. The Agenda for the Board and Committee meetings includes detailed notes on the
items to be discussed at the meeting to enable the Directors to take an informed decision.

During the Financial Year under review the Board of Directors duly met 6 times with gap
not exceeding the period prescribed under Companies Act, 2013 and Rules made thereunder.
The dates of the Board Meeting are mentioned below:


  

    
Sr.
    
Date of Board Meeting
    
Directors Attendance
  
  

    
No.
    

    
No. of Directors eligible to attend
    
No. of Directors attended
  
  

    
1.
    
29th May, 2024
    
6
    
6
  
  

    
2.
    
11th July, 2024
    
6
    
6
  
  

    
3.
    
15th July, 2024
    
6
    
6
  
  

    
4.
    
16th August, 2024
    
6
    
6
  
  

    
5.
    
13th November, 2024
    
6
    
6
  
  

    
6.
    
10th March,2025
    
6
    
6
  


The Annual General Meeting of the Company held on 9th September, 2024 for
the Financial Year 2023-24.


Board Committees


In compliance with the requirement of applicable laws and as part of best governance
practices, the Company has following Committees of the Board. i. Audit Committee ii.
Nomination and Remuneration Committee iii. Stakeholders' Relationship Committee iv.
Corporate Social Responsibility Committee 


A. Audit Committee Meetings


The composition of the Audit Committee is in conformity with the provisions of Section
177 of the Companies 

Act, 2013 and Regulation 18 of SEBI (Listing Obligation and Disclosure Requirement)
Regulations, 2015. 

The scope and terms of reference of the Audit Committee is in accordance with the Act
and the SEBI (LOBR) Regulations, 2015.

The Audit Committee comprised of:


  

    
Name of the Director
    
Designation in Committee
    
Nature of Directorship
  
  

    
Ms. Himani Bhootra
    
Chairman
    
Independent Director
  
  

    
Mr. Manish Tarachand Pande
    
Member
    
Independent Director
  
  

    
(Up to 9th April 2025)
    

    

  
  

    
Mr. Soham Sanjiv Vasant
    
Member
    
Director and CFO
  


During the Financial year ended on 31st March 2025, 4 (Four) meetings of the
Audit Committee were held on dates as mentioned below:


  

    
Sr.
    
Date of Audit Committee
    
Directors Attendance
  
  

    
No
    
Meeting
    
No. of Directors eligible to attend
    
No. of Directors attended
  
  

    
1.
    
29th May, 2024
    
3
    
3
  
  

    
2.
    
15th July, 2024
    
3
    
3
  
  

    
3.
    
16th August, 2024
    
3
    
3
  
  

    
4.
    
13th November, 2024
    
3
    
3
  



B. Nomination and Remuneration Committee


The Nomination and Remuneration Committee of Directors is constituted by the Board of
Directors of the Company in accordance with the requirements of Section 178 of the Act and
Regulation 19 of SEBI

(Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The Nomination and Remuneration Committee (hereinafter the "NRC Committee")
comprised of: 


  

    
Name of the Director
    
Designation in Committee
    
Nature of Directorship
  
  

    
Ms. Himani Bhootra
    
Chairman
    
Independent Director
  
  

    
Mr. Kunal Bharat Shingala
    
Member
    
Independent Director
  
  

    
Mr. Manish Tarachand Pande
    
Member
    
Independent Director
  
  

    
(Up to 9th April 2025)
    

    

  


During the Financial year ended on 31st March 2025, 1 (one) meetings of the
NRC Committee were held on dates as mentioned below:


  

    
Sr.
    
Date of Audit Committee
    
Directors Attendance
  
  

    
No
    
Meeting
    
No. of Directors eligible to attend
    
No. of Directors attended
  
  

    
1.
    
29th May, 2024
    
3
    
3
  



C. Stakeholders Relationship Committee


The Stakeholders Relationship Committee is constituted by the Board of Directors of the
Company in accordance with the requirements of Section 178 of the Act and Regulation 20 of
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Stakeholders
Relationship Committee comprises of: 


  

    
Name of the Director
    
Designation in Committee
    
Nature of Directorship
  
  

    
Mr. Kunal Bharat Shingala
    
Chairman
    
Independent Director
  
  

    
Mr. Shivam Sanjiv Vasant
    
Member
    
Whole-time director
  
  

    
Mr. Soham Sanjiv Vasant
    
Member
    
Director and CFO
  


The Committee met 1 time on 13th November, 2024 during the financial year.


  

    
Sr.
    
Date of Stakeholders
    
Directors Attendance
  
  

    
No
    
Relationship Meeting
    
No. of Directors eligible to attend
    
No. of Directors attended
  
  

    
1.
    
13th November, 2024
    
3
    
3
  



D. Corporate Social Responsibility Committee


During the financial year the Company was not required to spend any amount towards
Corporate Social Responsibility as the profits for the financial year ended 31 st
March, 2024 were below the threshold limit of Rs.5 Cr. for applicability of CSR. Whereas
the Company have constituted a Corporate Social Responsibility Committee and the Committee
consists of Independent Directors and Directors of the Company as listed below:


  

    
Name of the Director
    
Designation in Committee
    
Nature of Directorship
  
  

    
Mr. Soham Sanjiv Vasant
    
Chairman
    
Director & CFO
  
  

    
Mr. Kunal Bharat Shingala
    
Member
    
Independent Director
  
  

    
Mr. Manish Tarachand Pande
    
Member
    
Independent Director
  
  

    
(Up to 9th April 2025)
    

    

  



34. Conservation of Energy, Technology Absorption, Foreign Exchange Earnings and Outgo:


The information on Conservation of Energy, Technology Absorption and Foreign Exchange
Earnings and 

Outgo, as stipulated under Section 134(3)(m) of the Companies Act, 2013, read with
Rule, 8 of The Companies

(Accounts) Rules, 2014, is as below:


  

    
Particulars
    
FY 2024-25
    
FY 2023-24
  
  

    
Conservation of Energy, Technology, Absorption
    
NIL
    
NIL
  
  

    
Foreign Exchange Earnings
    
3111.77
    
NIL
  
  

    
Foreign Exchange Expenditure
    
2323.71
    
378.42
  



35. Related Party Transactions:

During the Financial year under review the Company has entered into related party
transactions and the details as per provisions of section 134(3)(h) of the Companies Act,
2013 read with provisions of rule 8 of the

Companies (Accounts) Rules, 2014, are as follows: